image
Protagonist Therapeutics, Inc. PTGX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 45.91
-1.69 %
$ 2.85 B
Market Cap
58.74
P/E
Price Target Average
33.49%
Revenue Forecast Estimate
2.27%
EBIT Estimate
--22.95%
Net Income Estimate
--4.98%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Protagonist Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for PTGX of $61.3 , with forecasts ranging from a low of $38 to a high of $76 .
PTGX Lowest Price Target Wall Street Target
38 USD -17.23%
PTGX Average Price Target Wall Street Target
61.3 USD 33.49%
PTGX Highest Price Target Wall Street Target
76 USD 65.54%
Price
Max Price Target
Min Price Target
Average Price Target
80807575707065656060555550504545404035353030Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart PTGX

image
$500.0m$500.0m$450.0m$450.0m$400.0m$400.0m$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart PTGX

image
$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)20172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart PTGX

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)20172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029